is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
NEX is a new zone showcasing the latest natural extract products, applications and solutions. Discover the natural extract and herbal industries in Thailand.
Simone Stoiber, Marketing Director at Harro Höfliger, gives her take on the future of pharma in SEA and why attending CPhI SEA is crucial for her company
We offer an effective way to raise your profile and grow your business across the Southeast Asian region - from one location, in just three days
Useful pre and in-event tools to help you maximise your time at CPhI South East Asia
“We are here in the hope of expanding our reach in this area: in Thailand and other countries in ASEAN. CPhI is a very important show, developing the pharmaceutical market and providing opportunities to manufacturers. Attending this exhibition is a wonderful occasion for us. Thanks to this event we will be able to supply our products to Thailand, which is our main focus.”
Technical Sales Manager
F.P.S. Foods and Pharma Systems S.r.l.
“I’m looking for business partners to export our products and Thailand is an attractive country in terms of market access. The show is a good opportunity for our company to find business partners around Thailand, Malaysia, Indonesia and Singapore.”
Sr. Executive Vice President
“I came from a pharmaceutical company in the United States. We manufacture medicines for the US market and Southeast Asian markets, including Thailand, Indonesia and Malaysia. That’s why I spent 24 hours just to be here. Usually, manufacturers in Asia don’t come to the United States and Europe but we want to expand here, so I came to meet companies face-to-face and create networks for our success. I’ve met some people from Australia and saw people from other parts of the world coming to CPhI to expand their business in ASEAN.”
Prabo Wijetunge, PhD
Executive Director (USA), CMC
Oyster Point Pharma